Taich Adam
Chief Financial Officer
Taich Adam has filed 5 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Sep 11, 2026.
On the most recent filing, Taich Adam is listed as Chief Financial Officer at 10x Genomics, Inc. Inside the rolling window, Taich Adam reported no open-market purchases and 4 open-market sales totaling $4.7M in TXG. The largest disclosed transaction in the window is a sale of 46,388 TXG shares on Sep 9, 2026, worth $3.0M.
Companies traded
Other insiders at TXG
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$4.7M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Taich Adam made?
Taich Adam has filed 5 SEC Form 4 filings (7 transaction rows) across 1 company since 2025.
Which companies does Taich Adam trade?
Taich Adam has filed SEC Form 4 disclosures for 1 company, including TXG.
When was Taich Adam's most recent SEC Form 4 filing?
Taich Adam's most recent SEC Form 4 filing on Tracefour is dated Sep 11, 2026.
What is Taich Adam's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Taich Adam is listed as Chief Financial Officer.
What is Taich Adam's total buy and sell value in the current window?
Inside the rolling retention window, Taich Adam bought $0 and sold $4.7M based on SEC Form 4 filings.
What was Taich Adam's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 46,388 TXG shares on 2026-09-09, worth $3.0M, per SEC Form 4 filings.